{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T08:19:58Z","timestamp":1771489198836,"version":"3.50.1"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T00:00:00Z","timestamp":1668816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T00:00:00Z","timestamp":1668816000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","award":["2020.10231.BD (DOCTORATES 4 COVID-19)"],"award-info":[{"award-number":["2020.10231.BD (DOCTORATES 4 COVID-19)"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Community Health"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1007\/s10900-022-01168-3","type":"journal-article","created":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T13:02:32Z","timestamp":1668862952000},"page":"295-308","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Motivation and Knowledge of Portuguese Community Pharmacists Towards the Reporting of Suspected Adverse Reactions to Medicines: A Cross-Sectional Survey"],"prefix":"10.1007","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6517-6021","authenticated-orcid":false,"given":"Renato","family":"Ferreira-da-Silva","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1248-4631","authenticated-orcid":false,"given":"Jo\u00e3o Miguel","family":"Alves","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2024-4021","authenticated-orcid":false,"given":"Carina","family":"Vieira","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2355-2310","authenticated-orcid":false,"given":"Ana Marta","family":"Silva","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1043-5078","authenticated-orcid":false,"given":"Joana","family":"Marques","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9509-0613","authenticated-orcid":false,"given":"Manuela","family":"Morato","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0133-7217","authenticated-orcid":false,"given":"Jorge Junqueira","family":"Pol\u00f3nia","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3442-8158","authenticated-orcid":false,"given":"In\u00eas","family":"Ribeiro-Vaz","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2022,11,19]]},"reference":[{"key":"1168_CR1","unstructured":"European Medicines Agency (2017). Guideline on Good Pharmacovigilance Practices (GVP): Annex I - Definitions. Available on: https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/guideline-good-pharmacovigilance-practices-annex-i-definitions-rev-4_en.pdf."},{"issue":"4","key":"1168_CR2","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1007\/s40267-017-0380-3","volume":"33","author":"C Matos","year":"2017","unstructured":"Matos, C., Rodrigues, L., & Joaquim, J. (2017). Attitudes and opinions of Portuguese community pharmacy professionals towards patient reporting of adverse drug reactions and the pharmacovigilance system. Drugs & Therapy Perspectives, 33(4), 188.","journal-title":"Drugs & Therapy Perspectives"},{"issue":"5","key":"1168_CR3","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1007\/s11096-012-9675-6","volume":"34","author":"SI dos Santos Pernas","year":"2012","unstructured":"dos Santos Pernas, S. I., Herdeiro, M. T., Lopez-Gonzalez, E., da Cruz e Silva, O. A. B., & Figueiras, A. (2012). Attitudes of Portuguese health professionals toward adverse drug reaction reporting. International Journal of Clinical Pharmacy, 34(5), 693\u2013698. https:\/\/doi.org\/10.1007\/s11096-012-9675-6","journal-title":"International Journal of Clinical Pharmacy"},{"issue":"4","key":"1168_CR4","doi-asserted-by":"publisher","first-page":"331","DOI":"10.2165\/00002018-200629040-00004","volume":"29","author":"MT Herdeiro","year":"2006","unstructured":"Herdeiro, M. T., Figueiras, A., Polonia, J., & Gestal-Otero, J. J. (2006). Influence of pharmacists\u2019 attitudes on adverse drug reaction reporting\u202f: A case-control study in Portugal. Drug Safety, 29(4), 331\u2013340. https:\/\/doi.org\/10.2165\/00002018-200629040-00004","journal-title":"Drug Safety"},{"issue":"1","key":"1168_CR5","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2165\/00002018-200932010-00002","volume":"32","author":"E Lopez-Gonzalez","year":"2009","unstructured":"Lopez-Gonzalez, E., Herdeiro, M. T., & Figueiras, A. (2009). Determinants of under-reporting of adverse drug reactions. Drug Safety, 32(1), 19\u201331. https:\/\/doi.org\/10.2165\/00002018-200932010-00002","journal-title":"Drug Safety"},{"issue":"3","key":"1168_CR6","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1111\/jonm.12337","volume":"24","author":"JIO Mendes Marques","year":"2016","unstructured":"Mendes Marques, J. I. O., Pol\u00f3nia, J. M. J., Figueiras, A. G., Costa Santos, C. M. N., & Herdeiro, M. T. F. (2016). Nurses\u2019 attitudes and spontaneous adverse drug reaction reporting: A case\u2013control study in Portugal. Journal of nursing management, 24(3), 409\u2013416.","journal-title":"Journal of nursing management"},{"issue":"8","key":"1168_CR7","doi-asserted-by":"publisher","first-page":"e0235591","DOI":"10.1371\/journal.pone.0235591","volume":"15","author":"M Potlog Shchory","year":"2020","unstructured":"Potlog Shchory, M., Goldstein, L. H., Arcavi, L., Shihmanter, R., Berkovitch, M., & Levy, A. (2020). Increasing adverse drug reaction reporting-How can we do better? PLoS ONE, 15(8), e0235591. https:\/\/doi.org\/10.1371\/journal.pone.0235591","journal-title":"PLoS ONE"},{"issue":"1","key":"1168_CR8","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1046\/j.1365-2125.2001.01306.x","volume":"51","author":"CF Green","year":"2001","unstructured":"Green, C. F., Mottram, D. R., Rowe, P. H., & Pirmohamed, M. (2001). Attitudes and knowledge of hospital pharmacists to adverse drug reaction reporting. British Journal of Clinical Pharmacology, 51(1), 81\u201386. https:\/\/doi.org\/10.1046\/j.1365-2125.2001.01306.x","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"9","key":"1168_CR9","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1007\/s40267-015-0227-8","volume":"31","author":"M Duarte","year":"2015","unstructured":"Duarte, M., Ferreira, P., Soares, M., Cavaco, A., & Martins, A. P. (2015). Community pharmacists\u2019 attitudes towards adverse drug reaction reporting and their knowledge of the new pharmacovigilance legislation in the southern region of Portugal: A mixed methods study. Drugs & Therapy Perspectives, 31(9), 316\u2013322. https:\/\/doi.org\/10.1007\/s40267-015-0227-8","journal-title":"Drugs & Therapy Perspectives"},{"issue":"4","key":"1168_CR10","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1007\/s11096-018-0700-2","volume":"40","author":"R Li","year":"2018","unstructured":"Li, R., Curtain, C., Bereznicki, L., & Zaidi, S. T. R. (2018). Community pharmacists\u2019 knowledge and perspectives of reporting adverse drug reactions in Australia: A cross-sectional survey. International Journal of Clinical Pharmacy, 40(4), 878\u2013889. https:\/\/doi.org\/10.1007\/s11096-018-0700-2","journal-title":"International Journal of Clinical Pharmacy"},{"key":"1168_CR11","unstructured":"Organisation WH: The importance of pharmacovigilance: safety Monitoring of medicinal products. https:\/\/www.who.int\/publications\/i\/item\/10665-42493 (2002). Accessed."},{"issue":"7140","key":"1168_CR12","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1136\/bmj.316.7140.1295","volume":"316","author":"M Pirmohamed","year":"1998","unstructured":"Pirmohamed, M., Breckenridge, A. M., Kitteringham, N. R., & Park, B. K. (1998). Adverse drug reactions. BMJ, 316(7140), 1295\u20131298. https:\/\/doi.org\/10.1136\/bmj.316.7140.1295","journal-title":"BMJ"},{"issue":"4","key":"1168_CR13","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1046\/j.1365-2125.1996.04376.x","volume":"42","author":"CC Smith","year":"1996","unstructured":"Smith, C. C., Bennett, P. M., Pearce, H. M., Harrison, P. I., Reynolds, D. J., Aronson, J. K., et al. (1996). Adverse drug reactions in a hospital general medical unit meriting notification to the Committee on Safety of Medicines. British Journal of Clinical Pharmacology, 42(4), 423\u2013429. https:\/\/doi.org\/10.1046\/j.1365-2125.1996.04376.x","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"1","key":"1168_CR14","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0035-8819(25)00659-2","volume":"29","author":"MD Rawlins","year":"1995","unstructured":"Rawlins, M. D. (1995). Pharmacovigilance: Paradise lost, regained or postponed? The William Withering Lecture 1994. Journal of the Royal College of Physicians of London, 29(1), 41\u201349.","journal-title":"Journal of the Royal College of Physicians of London"},{"issue":"1","key":"1168_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2125.1988.tb03356.x","volume":"26","author":"MD Rawlins","year":"1988","unstructured":"Rawlins, M. D. (1988). Spontaneous reporting of adverse drug reactions. I: the data. British Journal of Clinical Pharmacology, 26(1), 1\u20135. https:\/\/doi.org\/10.1111\/j.1365-2125.1988.tb03356.x","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"6","key":"1168_CR16","doi-asserted-by":"publisher","first-page":"450","DOI":"10.2165\/00002018-199106060-00005","volume":"6","author":"L Ibanez","year":"1991","unstructured":"Ibanez, L., Laporte, J. R., & Carne, X. (1991). Adverse drug reactions leading to hospital admission. Drug Safety, 6(6), 450\u2013459. https:\/\/doi.org\/10.2165\/00002018-199106060-00005","journal-title":"Drug Safety"},{"issue":"9","key":"1168_CR17","doi-asserted-by":"publisher","first-page":"825","DOI":"10.2165\/00002018-200528090-00007","volume":"28","author":"MT Herdeiro","year":"2005","unstructured":"Herdeiro, M. T., Figueiras, A., Polonia, J., & Gestal-Otero, J. J. (2005). Physicians\u2019 attitudes and adverse drug reaction reporting\u202f: A case-control study in Portugal. Drug Safety, 28(9), 825\u2013833. https:\/\/doi.org\/10.2165\/00002018-200528090-00007","journal-title":"Drug Safety"},{"issue":"2","key":"1168_CR18","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/j.2042-7174.1999.tb00955.x","volume":"7","author":"CF Green","year":"2011","unstructured":"Green, C. F., Mottram, D. R., Raval, D., Proudlove, C., & Randall, C. (2011). Community pharmacists\u2019 attitudes to adverse drug reaction reporting. International Journal of Pharmacy Practice, 7(2), 92\u201399. https:\/\/doi.org\/10.1111\/j.2042-7174.1999.tb00955.x","journal-title":"International Journal of Pharmacy Practice"},{"issue":"4","key":"1168_CR19","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1177\/106002809502900404","volume":"29","author":"JA Generali","year":"1995","unstructured":"Generali, J. A., Danish, M. A., & Rosenbaum, S. E. (1995). Knowledge of and attitudes about adverse drug reaction reporting among Rhode Island pharmacists. Annals of Pharmacotherapy, 29(4), 365\u2013369. https:\/\/doi.org\/10.1177\/106002809502900404","journal-title":"Annals of Pharmacotherapy"},{"issue":"1","key":"1168_CR20","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1186\/s12913-019-4133-y","volume":"19","author":"SA Yousuf","year":"2019","unstructured":"Yousuf, S. A., Alshakka, M., Badulla, W. F. S., Ali, H. S., Shankar, P. R., & Mohamed Ibrahim, M. I. (2019). Attitudes and practices of community pharmacists and barriers to their participation in public health activities in Yemen: Mind the gap. BMC Health Services Research, 19(1), 304. https:\/\/doi.org\/10.1186\/s12913-019-4133-y","journal-title":"BMC Health Services Research"},{"issue":"2","key":"1168_CR21","doi-asserted-by":"publisher","first-page":"165","DOI":"10.2165\/00002018-200023020-00006","volume":"23","author":"D Sweis","year":"2000","unstructured":"Sweis, D., & Wong, I. C. (2000). A survey on factors that could affect adverse drug reaction reporting according to hospital pharmacists in Great Britain. Drug Safety, 23(2), 165\u2013172. https:\/\/doi.org\/10.2165\/00002018-200023020-00006","journal-title":"Drug Safety"},{"issue":"1","key":"1168_CR22","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40545-022-00417-z","volume":"15","author":"T Kitisopee","year":"2022","unstructured":"Kitisopee, T., Assanee, J., Sorofman, B. A., & Watcharadmrongkun, S. (2022). Consumers\u2019 adverse drug event reporting via community pharmacists: Three stakeholder perception. Journal of Pharmaceutical Policy and Practice, 15(1), 19. https:\/\/doi.org\/10.1186\/s40545-022-00417-z","journal-title":"Journal of Pharmaceutical Policy and Practice"},{"issue":"4","key":"1168_CR23","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1080\/03007995.2022.2042992","volume":"38","author":"MJH Sharif","year":"2022","unstructured":"Sharif, M. J. H., Farrukh, M. J., Khan, F. U., Khan, Q., Ahmed, S. S., Kousar, R., et al. (2022). Exploring the factors and barriers of healthcare professionals in tertiary care hospitals toward pharmacovigilance: A multicenter study from Khyber Pakhtunkhwa Pakistan. Current Medical Research and Opinion, 38(4), 595\u2013605. https:\/\/doi.org\/10.1080\/03007995.2022.2042992","journal-title":"Current Medical Research and Opinion"},{"issue":"4","key":"1168_CR24","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1007\/s11096-018-0700-2","volume":"40","author":"R Li","year":"2018","unstructured":"Li, R., Curtain, C., Bereznicki, L., & Zaidi, S. T. R. (2018). Community pharmacists\u2019 knowledge and perspectives of reporting adverse drug reactions in Australia: A cross-sectional survey. International Journal of Clinical Pharmacy, 40(4), 878\u2013889. https:\/\/doi.org\/10.1007\/s11096-018-0700-2","journal-title":"International Journal of Clinical Pharmacy"},{"issue":"8","key":"1168_CR25","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.3390\/healthcare9081072","volume":"9","author":"A Valinciute-Jankauskiene","year":"2021","unstructured":"Valinciute-Jankauskiene, A., & Kubiliene, L. (2021). Qualitative Study of Community Pharmacists\u2019 and General Practitioners\u2019 Views toward Pharmacovigilance in Lithuania. Healthcare, 9(8), 1072.","journal-title":"Healthcare"},{"issue":"3","key":"1168_CR26","doi-asserted-by":"publisher","first-page":"e34","DOI":"10.2196\/jmir.6.3.e34","volume":"6","author":"G Eysenbach","year":"2004","unstructured":"Eysenbach, G. (2004). Improving the quality of Web surveys: The checklist for reporting results of internet E-surveys (CHERRIES). Journal of Medical Internet Research, 6(3), e34. https:\/\/doi.org\/10.2196\/jmir.6.3.e34","journal-title":"Journal of Medical Internet Research"},{"issue":"12","key":"1168_CR27","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1016\/j.sapharm.2019.01.007","volume":"15","author":"D De Meestere","year":"2019","unstructured":"De Meestere, D., & Saevels, J. (2019). Belgian community pharmacists\u2019 pharmacovigilance perspective and practice. Research in Social and Administrative Pharmacy., 15(12), 1446\u20131452. https:\/\/doi.org\/10.1016\/j.sapharm.2019.01.007","journal-title":"Research in Social and Administrative Pharmacy."},{"issue":"12","key":"1168_CR28","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1002\/pds.4800","volume":"28","author":"ML Hughes","year":"2019","unstructured":"Hughes, M. L., & Weiss, M. (2019). Adverse drug reaction reporting by community pharmacists\u2014the barriers and facilitators. Pharmacoepidemiology and drug safety., 28(12), 1552\u20131559.","journal-title":"Pharmacoepidemiology and drug safety."},{"issue":"10","key":"1168_CR29","doi-asserted-by":"publisher","first-page":"e00304420","DOI":"10.1590\/0102-311X00304420","volume":"37","author":"R Ferreira-da-Silva","year":"2021","unstructured":"Ferreira-da-Silva, R., Ribeiro-Vaz, I., Silva, A. M., Marques, J., & Polonia, J. J. (2021). Looking back on 20 years of work at the Porto Pharmacovigilance Centre, Portugal. Cadernos de Sa\u00fade P\u00fablica, 37(10), e00304420. https:\/\/doi.org\/10.1590\/0102-311X00304420","journal-title":"Cadernos de Sa\u00fade P\u00fablica"},{"key":"1168_CR30","unstructured":"Grootheest ACV. (2003). Improving pharmacovigilance and the role of the pharmacist. Groningen: s.n., (pp. 230)."},{"key":"1168_CR31","unstructured":"Infarmed \u2013 National Authority of Medicines and Health Products IP: Notifica\u00e7\u00e3o de rea\u00e7\u00f5es adversas a medicamentos - Desempenho do Sistema Nacional de Farmacovigil\u00e2ncia. https:\/\/www.infarmed.pt\/web\/infarmed\/entidades\/medicamentos-uso-humano\/farmacovigilancia\/desempenho-do-snf (2022). Accessed 30 May 2022."},{"key":"1168_CR32","doi-asserted-by":"publisher","DOI":"10.1590\/0102-311X00304420","author":"IR-V Renato Ferreira-da-Silva","year":"2021","unstructured":"Renato Ferreira-da-Silva, I.R.-V., Silva, A. M., Marques, J., & Pol\u00f3nia, J. J. (2021). Retrospectiva de 20 anos de atividade da Unidade de Farmacovigil\u00e2ncia do Porto Portugal. Cadernos de Sa\u00fade P\u00fablica. https:\/\/doi.org\/10.1590\/0102-311X00304420","journal-title":"Cadernos de Sa\u00fade P\u00fablica"},{"issue":"7","key":"1168_CR33","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1002\/pds.1752","volume":"18","author":"H Xu","year":"2009","unstructured":"Xu, H., Wang, Y., & Liu, N. (2009). A hospital-based survey of healthcare professionals in the awareness of pharmacovigilance. Pharmacoepidemiology and Drug Safety, 18(7), 624\u2013630. https:\/\/doi.org\/10.1002\/pds.1752","journal-title":"Pharmacoepidemiology and Drug Safety"},{"issue":"3","key":"1168_CR34","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1002\/pds.1792","volume":"19","author":"C Su","year":"2010","unstructured":"Su, C., Ji, H., & Su, Y. (2010). Hospital pharmacists\u2019 knowledge and opinions regarding adverse drug reaction reporting in Northern China. Pharmacoepidemiology and Drug Safety, 19(3), 217\u2013222. https:\/\/doi.org\/10.1002\/pds.1792","journal-title":"Pharmacoepidemiology and Drug Safety"},{"issue":"2","key":"1168_CR35","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.jsps.2014.07.001","volume":"23","author":"M Suyagh","year":"2015","unstructured":"Suyagh, M., Farah, D., & Abu, F. R. (2015). Pharmacist\u2019s knowledge, practice and attitudes toward pharmacovigilance and adverse drug reactions reporting process. Saudi Pharm J, 23(2), 147\u2013153. https:\/\/doi.org\/10.1016\/j.jsps.2014.07.001","journal-title":"Saudi Pharm J"},{"issue":"5","key":"1168_CR36","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1007\/s11096-008-9209-4","volume":"30","author":"HZ Toklu","year":"2008","unstructured":"Toklu, H. Z., & Uysal, M. K. (2008). The knowledge and attitude of the Turkish community pharmacists toward pharmacovigilance in the Kadikoy district of Istanbul. Pharmacy World & Science, 30(5), 556\u2013562. https:\/\/doi.org\/10.1007\/s11096-008-9209-4","journal-title":"Pharmacy World & Science"},{"issue":"2","key":"1168_CR37","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s11096-008-9276-6","volume":"31","author":"G Vessal","year":"2009","unstructured":"Vessal, G., Mardani, Z., & Mollai, M. (2009). Knowledge, attitudes, and perceptions of pharmacists to adverse drug reaction reporting in Iran. Pharmacy World & Science, 31(2), 183\u2013187. https:\/\/doi.org\/10.1007\/s11096-008-9276-6","journal-title":"Pharmacy World & Science"},{"issue":"5","key":"1168_CR38","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.jsps.2013.07.005","volume":"22","author":"MA Mahmoud","year":"2014","unstructured":"Mahmoud, M. A., Alsowaida, Y., Alshammari, T., Khan, T. M., Alrasheedy, A., Hassali, M. A., et al. (2014). Community pharmacists\u2019 knowledge, behaviors and experiences about adverse drug reaction reporting in Saudi Arabia. Saudi Pharm J, 22(5), 411\u2013418. https:\/\/doi.org\/10.1016\/j.jsps.2013.07.005","journal-title":"Saudi Pharm J"},{"key":"1168_CR39","unstructured":"Organization WH: Safety Monitoring of Medicinal Products: Guidelines for setting up and running a pharmacovigilance centre 2000\u2014section 5.3 under-reporting. https:\/\/digicollections.net\/medicinedocs\/#p\/home (2020). Accessed 20 Jan 2022."},{"key":"1168_CR40","first-page":"17","volume-title":"Epidemiological issues in reported drug-induced illnesses","author":"W Inman","year":"1976","unstructured":"Inman, W. (1976). Assessment drug safety problems. Epidemiological issues in reported drug-induced illnesses (pp. 17\u201324). McMaster University Library Press Honolulu."},{"issue":"7","key":"1168_CR41","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1001\/archinte.1988.00380070090021","volume":"148","author":"AS Rogers","year":"1988","unstructured":"Rogers, A. S., Israel, E., Smith, C. R., Levine, D., McBean, A. M., Valente, C., et al. (1988). Physician knowledge, attitudes, and behavior related to reporting adverse drug events. Archives of Internal Medicine, 148(7), 1596\u20131600.","journal-title":"Archives of Internal Medicine"},{"issue":"8","key":"1168_CR42","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1097\/00005650-199908000-00010","volume":"37","author":"A Figueiras","year":"1999","unstructured":"Figueiras, A., Tato, F., Fontai\u00f1as, J., & Gestal-Otero, J. J. (1999). Influence of physicians\u2019 attitudes on reporting adverse drug events: A case-control study. Medical Care, 37(8), 809\u2013814. https:\/\/doi.org\/10.1097\/00005650-199908000-00010","journal-title":"Medical Care"},{"issue":"4","key":"1168_CR43","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1046\/j.1365-2125.1999.00060.x","volume":"48","author":"IA Eland","year":"1999","unstructured":"Eland, I. A., Belton, K. J., van Grootheest, A. C., Meiners, A. P., Rawlins, M. D., & Stricker, B. H. (1999). Attitudinal survey of voluntary reporting of adverse drug reactions. British Journal of Clinical Pharmacology, 48(4), 623\u2013627. https:\/\/doi.org\/10.1046\/j.1365-2125.1999.00060.x","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"5","key":"1168_CR44","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1365-2125.1992.tb05646.x","volume":"34","author":"DN Bateman","year":"1992","unstructured":"Bateman, D. N., Sanders, G. L., & Rawlins, M. D. (1992). Attitudes to adverse drug reaction reporting in the Northern Region. British Journal of Clinical Pharmacology, 34(5), 421\u2013426.","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"3","key":"1168_CR45","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/j.1365-2125.1995.tb04440.x","volume":"39","author":"KJ Belton","year":"1995","unstructured":"Belton, K. J., Lewis, S. C., Payne, S., Rawlins, M. D., & Wood, S. M. (1995). Attitudinal survey of adverse drug reaction reporting by medical practitioners in the United Kingdom. British Journal of Clinical Pharmacology, 39(3), 223\u2013226. https:\/\/doi.org\/10.1111\/j.1365-2125.1995.tb04440.x","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"9","key":"1168_CR46","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s002280000202","volume":"56","author":"M B\u00e4ckstr\u00f6m","year":"2000","unstructured":"B\u00e4ckstr\u00f6m, M., Mj\u00f6rndal, T., Dahlqvist, R., & Nordkvist-Olsson, T. (2000). Attitudes to reporting adverse drug reactions in northern Sweden. European Journal of Clinical Pharmacology, 56(9), 729\u2013732. https:\/\/doi.org\/10.1007\/s002280000202","journal-title":"European Journal of Clinical Pharmacology"},{"issue":"1","key":"1168_CR47","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1046\/j.1365-2125.1997.00616.x","volume":"44","author":"P McGettigan","year":"1997","unstructured":"McGettigan, P., Golden, J., Conroy, R. M., Arthur, N., & Feely, J. (1997). Reporting of adverse drug reactions by hospital doctors and the response to intervention. British Journal of Clinical Pharmacology, 44(1), 98\u2013100. https:\/\/doi.org\/10.1046\/j.1365-2125.1997.00616.x","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"5","key":"1168_CR48","doi-asserted-by":"publisher","first-page":"96","DOI":"10.5688\/ajpe75596","volume":"75","author":"RM Elkalmi","year":"2011","unstructured":"Elkalmi, R. M., Hassali, M. A., Ibrahim, M. I., Widodo, R. T., Efan, Q. M., & Hadi, M. A. (2011). Pharmacy students\u2019 knowledge and perceptions about pharmacovigilance in Malaysian public universities. American Journal of Pharmaceutical Education, 75(5), 96. https:\/\/doi.org\/10.5688\/ajpe75596","journal-title":"American Journal of Pharmaceutical Education"},{"issue":"3","key":"1168_CR49","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/pds.3311","volume":"22","author":"MP Smith","year":"2013","unstructured":"Smith, M. P., & Webley, S. D. (2013). Pharmacovigilance teaching in UK undergraduate pharmacy programmes. Pharmacoepidemiology and Drug Safety, 22(3), 223\u2013228. https:\/\/doi.org\/10.1002\/pds.3311","journal-title":"Pharmacoepidemiology and Drug Safety"},{"issue":"1","key":"1168_CR50","first-page":"13","volume":"18","author":"JC Medeiros","year":"2017","unstructured":"Medeiros, J. C., Ferreira, S. C., & Paix\u00e3o, MNd. J. (2017). Knowledge about adverse drug reaction between pharmacy and nursing students. Revista de Pesquisa em Sa\u00fade, 18(1), 13\u201317.","journal-title":"Revista de Pesquisa em Sa\u00fade"},{"issue":"4","key":"1168_CR51","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1002\/pds.1298","volume":"16","author":"AG Granas","year":"2007","unstructured":"Granas, A. G., Buajordet, M., Stenberg-Nilsen, H., Harg, P., & Horn, A. M. (2007). Pharmacists\u2019 attitudes towards the reporting of suspected adverse drug reactions in Norway. Pharmacoepidemiology and Drug Safety, 16(4), 429\u2013434. https:\/\/doi.org\/10.1002\/pds.1298","journal-title":"Pharmacoepidemiology and Drug Safety"},{"issue":"5","key":"1168_CR52","doi-asserted-by":"publisher","first-page":"385","DOI":"10.2165\/00002018-200629050-00003","volume":"29","author":"L Hazell","year":"2006","unstructured":"Hazell, L., & Shakir, S. A. (2006). Under-reporting of adverse drug reactions\u202f: A systematic review. Drug Safety, 29(5), 385\u2013396. https:\/\/doi.org\/10.2165\/00002018-200629050-00003","journal-title":"Drug Safety"},{"key":"1168_CR53","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/j.2042-7174.1997.tb00906.x","volume":"5","author":"CF Green","year":"1997","unstructured":"Green, C. F., Mottram, D. R., Rowe, P. H., & Brown, A. M. (1997). An investigation into adverse drug reaction monitoring by United Kingdom hospital pharmacy departments. International Journal of Pharmacy Practice, 5, 202\u2013208.","journal-title":"International Journal of Pharmacy Practice"},{"issue":"2","key":"1168_CR54","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s11096-013-9882-9","volume":"36","author":"AM Cavaco","year":"2014","unstructured":"Cavaco, A. M., & Krookas, A. A. (2014). Community pharmacies automation: Any impact on counselling duration and job satisfaction? International Journal of Clinical Pharmacy, 36(2), 325\u2013335. https:\/\/doi.org\/10.1007\/s11096-013-9882-9","journal-title":"International Journal of Clinical Pharmacy"},{"key":"1168_CR55","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1177\/009286151104500613","volume":"45","author":"B Rouleau","year":"2011","unstructured":"Rouleau, B., Lavoie, L., Leblanc, J., Moretti, S., & Collin, C. (2011). Reporting of adverse drug reactions by community pharmacists: A qualitative study in quebec. Drug Information Journal., 45, 627\u2013639.","journal-title":"Drug Information Journal."},{"issue":"11","key":"1168_CR56","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.2165\/00002018-200730110-00006","volume":"30","author":"M Irujo","year":"2007","unstructured":"Irujo, M., Beitia, G., Bes-Rastrollo, M., Figueiras, A., Hern\u00e1ndez-D\u00edaz, S., & Lasheras, B. (2007). Factors that influence under-reporting of suspected adverse drug reactions among community pharmacists in a Spanish region. Drug Safety, 30(11), 1073\u20131082. https:\/\/doi.org\/10.2165\/00002018-200730110-00006","journal-title":"Drug Safety"},{"key":"1168_CR57","unstructured":"Rep\u00fablica Dd: Decreto-Lei n.\u00ba 176\/2006 - Regime jur\u00eddico dos medicamentos de uso humano. https:\/\/dre.pt\/dre\/detalhe\/decreto-lei\/176-2006-540387 Accessed."},{"key":"1168_CR58","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1186\/1471-2458-9-274","volume":"9","author":"M Tabali","year":"2009","unstructured":"Tabali, M., Jeschke, E., Bockelbrink, A., Witt, C. M., Willich, S. N., Ostermann, T., et al. (2009). Educational intervention to improve physician reporting of adverse drug reactions (ADRs) in a primary care setting in complementary and alternative medicine. BMC Public Health, 9, 274. https:\/\/doi.org\/10.1186\/1471-2458-9-274","journal-title":"BMC Public Health"},{"key":"1168_CR59","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1186\/1472-6963-13-313","volume":"13","author":"A Parrella","year":"2013","unstructured":"Parrella, A., Braunack-Mayer, A., Gold, M., Marshall, H., & Baghurst, P. (2013). Healthcare providers\u2019 knowledge, experience and challenges of reporting adverse events following immunisation: A qualitative study. BMC Health Services Research, 13, 313. https:\/\/doi.org\/10.1186\/1472-6963-13-313","journal-title":"BMC Health Services Research"},{"issue":"1","key":"1168_CR60","doi-asserted-by":"publisher","first-page":"e000367","DOI":"10.1136\/bmjopen-2011-000367","volume":"2","author":"H Khalili","year":"2012","unstructured":"Khalili, H., Mohebbi, N., Hendoiee, N., Keshtkar, A. A., & Dashti-Khavidaki, S. (2012). Improvement of knowledge, attitude and perception of healthcare workers about ADR, a pre- and post-clinical pharmacists\u2019 interventional study. British Medical Journal Open, 2(1), e000367. https:\/\/doi.org\/10.1136\/bmjopen-2011-000367","journal-title":"British Medical Journal Open"},{"issue":"5","key":"1168_CR61","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s40264-016-0494-x","volume":"40","author":"ST de Vries","year":"2017","unstructured":"de Vries, S. T., Wong, L., Sutcliffe, A., Houyez, F., Ruiz, C. L., Mol, P. G., et al. (2017). Factors influencing the use of a mobile app for reporting adverse drug reactions and receiving safety Information: A qualitative study. Drug Safety, 40(5), 443\u2013455. https:\/\/doi.org\/10.1007\/s40264-016-0494-x","journal-title":"Drug Safety"},{"issue":"5","key":"1168_CR62","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s40264-017-0630-2","volume":"41","author":"F Montastruc","year":"2018","unstructured":"Montastruc, F., Bagheri, H., Lacroix, I., Damase-Michel, C., Chebane, L., Rousseau, V., et al. (2018). Adverse drug reaction reports received through the mobile app, VigiBIP((R)): A comparison with classical methods of reporting. Drug Safety, 41(5), 511\u2013514. https:\/\/doi.org\/10.1007\/s40264-017-0630-2","journal-title":"Drug Safety"},{"issue":"12","key":"1168_CR63","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1517\/14740338.2015.1096342","volume":"14","author":"R Ghosh","year":"2015","unstructured":"Ghosh, R., & Lewis, D. (2015). Aims and approaches of Web-RADR: A consortium ensuring reliable ADR reporting via mobile devices and new insights from social media. Expert Opinion on Drug Safety, 14(12), 1845\u20131853. https:\/\/doi.org\/10.1517\/14740338.2015.1096342","journal-title":"Expert Opinion on Drug Safety"},{"issue":"4","key":"1168_CR64","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1111\/j.1365-2753.2003.00456.x","volume":"10","author":"MT Herdeiro","year":"2004","unstructured":"Herdeiro, M. T., Pol\u00f3nia, J., Gestal-Otero, J. J., & Figueiras, A. (2004). Factors that influence spontaneous reporting of adverse drug reactions: A model centralized in the medical professional. Journal of evaluation in clinical practice, 10(4), 483\u2013489.","journal-title":"Journal of evaluation in clinical practice"},{"key":"1168_CR65","doi-asserted-by":"publisher","first-page":"222","DOI":"10.4321\/S1886-36552012000400006","volume":"10","author":"A Prakasam","year":"2012","unstructured":"Prakasam, A., Nidamanuri, A., & Kumar, S. (2012). Knowledge, perception and practice of pharmacovigilance among community pharmacists in South India. Pharmacy Practice (Granada), 10, 222\u2013226.","journal-title":"Pharmacy Practice (Granada)"}],"container-title":["Journal of Community Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10900-022-01168-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10900-022-01168-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10900-022-01168-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:20:42Z","timestamp":1744158042000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10900-022-01168-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,19]]},"references-count":65,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["1168"],"URL":"https:\/\/doi.org\/10.1007\/s10900-022-01168-3","relation":{},"ISSN":["0094-5145","1573-3610"],"issn-type":[{"value":"0094-5145","type":"print"},{"value":"1573-3610","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,19]]},"assertion":[{"value":"2 November 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All procedures followed the ethical standards of the ethics committee of the Centro Hospitalar e Universit\u00e1rio de S\u00e3o Jo\u00e3o and the Helsinki Declaration of 1964 and its later amendments. This ethics committee approved the study (CE-82-21).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Informed consent was obtained from the participants for being included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Informed consent was obtained from the participants to publish data in an aggregated form under scientific publication.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}]}}